Abstract
This study evaluated the effects of different doses of atropine and new antiepileptics, levetiracetam and topiramate, on the development of convulsions triggered by food intake in antimuscarinic-treated fasted animals. Mice deprived of food for 24 h and treated i.p. with atropine at a dose of 2.4 or 24 mg/kg developed convulsions after being allowed to eat ad libitum. No convulsions were observed in fasted animals treated with 0.24 mg/kg atropine. There was no difference in the incidence of convulsions between the two atropine treatments, but latency to convulsions was longer in 24 mg/kg atropine treated animals. The lowest dose of atropine, 0.24 mg/kg, caused stage 1 and stage 2 activity, but did not provide the convulsive endpoint (stage 3, 4, 5 activity). Administration of levetiracetam (50 or 200 mg/kg) or topiramate (50 or 100 mg/kg) to another group of 24-h fasted mice was ineffective in reducing the incidence of convulsions developed in the animals after 2.4 mg/kg atropine treatment and food intake. However, the higher dose of levetiracetam prolonged the onset of convulsions. Present results demonstrated the efficacy of low and high doses of atropine on the development of convulsions in fasted animals and provided additional evidence for the ineffectiveness of antiepileptic treatment in these seizures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albrecht C, Bloss HG, Jackisch R, Feuerstein TJ (1999) Evaluation of autoreceptor-mediated control of [(3)H]acetylcholine release in rat and human neocortex. Exp Brain Res 128:383–389. doi:10.1007/s002210050858
Anderson DR, Harris LW, Bowersox SL, Lennox WJ, Anders JC (1994) Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug Chem Toxicol 17:139–148. doi:10.3109/01480549409014307
Baghdoyan HA, Lydic R, Fleegal MA (1998) M2 muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation. J Pharmacol Exp Ther 286:1446–1452
Bell LA, Bell KA, McQuiston AR (2015) Acetylcholine release in mouse hippocampal CA1 preferentially activates inhibitory-selective interneurons via α4β2* nicotinic receptor activation. Front Cell Neurosci 9:115. doi:10.3389/fncel.2015.00115
Brown DA (2010) Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms. J Mol Neurosci 41:340–346. doi:10.1007/s12031-010-9377-2
Enginar N, Nurten A (2010) Seizures triggered by food intake in antimuscarinic-treated fasted animals: evaluation of the experimental findings in terms of similarities to eating-triggered epilepsy. Epilepsia 51(Suppl 3):80–84. doi:10.1111/j.1528-1167.2010.02616.x
Enginar N, Nurten A, Yamantürk-Çelik P, Açıkmeşe B (2005) Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs. Neuropharmacology 49:293–299. doi:10.1016/j.neuropharm.2005.01.032
Enginar N, Nurten A, Özünal ZG, Zengin A (2009) Scopolamine-induced convulsions in fasted mice after food intake: the effect of food deprivation. Epilepsia 50:143–146. doi:10.1111/j.1528-1167.2008.01786.x
Goldbach R, Allgaier C, Heimrich B, Jackisch R (1998) Postnatal development of muscarinic autoreceptors modulating acetylcholine release in the septohippocampal cholinergic system. I. Axon terminal region: hippocampus. Brain Res Dev Brain Res 108:23–30. doi:10.1016/S0165-3806(98)00026-1
Guimaraes J, Simoes-Riberio F, Mendes-Riberio JA, Abreu P, Pires I, Georgina S (2005) Eating seizures and emotional facial paresis: evidence suggesting the amygdala is a common anatomophysiological substratum. Epilepsy Behav 6:266–269. doi:10.1016/j.yebeh.2004.11.016
Iwanaga K, Murata T, Okada M, Hori M, Ozaki H (2009) Carbachol induces Ca2+-dependent contraction via muscarinic M2 and M3 receptors in rat intestinal subepithelial myofibroblasts. J Pharmacol Sci 110:306–314. doi:10.1254/jphs.09118FP
Kaminski RM, Banerjee M, Rogawski MA (2004) Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology 46:1097–1104. doi:10.1016/j.neuropharm.2004.02.010
Kammerer M, Brawek B, Freiman TM, Jackisch R, Feuerstein TJ (2011) Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes. Naunyn-Schmied Arch Pharmacol 383:531–542. doi:10.1007/s00210-011-0620-3
Kichigina VF, Butuzova MV, Sinel’nikova VV (2007) Medial septal region as a target for modulation of seizure discharges in the hippocampus in a model of acute temporal lobe epilepsy. Zh Vyssh Nerv Deiat Im I P Pavlova 57:52–64
Klein S, Bankstahl M, Löscher W (2015) Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Neuropharmacology 90:53–62. doi:10.1016/j.neuropharm.2014.11.008
Kumari A, Sreetama S, Mohanakumar KP (2007) Atropine, a muscarinic receptor antagonist increases serotonin, but not dopamine levels in discrete brain regions of mice. Neurosci Lett 423:100–103. doi:10.1016/j.neulet.2007.06.027
Lee CY, Chen CC, Liou HH (2009) Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus. Br J Pharmacol 158:1753–1762. doi:10.1111/j.1476-5381.2009.00463.x
Lukyanetz EA, Shkryl VM, Kostyuk PG (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:9–18. doi:10.1046/j.1528-1157.2002.24501.x
Luszczki JJ, Trojnar MK, Trojnar MP, Kimber-Trojnar Z, Szostakiewicz B, Zadrozniak A, Borowicz KK, Czuczwar SJ (2008) Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice. Can J Physiol Pharmacol 86:113–121
Maslanski JA, Powelt R, Deirmengiant C, Patelt J (1994) Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice. Neurosci Lett 168:225–258. doi:10.1016/0304-3940(94)90456-1
Meyer EM, Otero DH (1985) Pharmacological and ionic characterizations of the muscarinic receptors modulating [3H]acetylcholine release from rat cortical synaptosomes. J Neurosci 5:1202–1207
Nurten A, Enginar N (2006) The evaluation of antimuscarinic-induced convulsions in fasted rats after food intake. Epilepsy Res 72:171–177. doi:10.1016/j.eplepsyres.2006.07.018
Nurten A, Özen İ, Karamürsel S, Kara İ (2006) Electroencephalographic characterization of scopolamine-induced convulsions in fasted mice after food intake. Seizure 15:509–519. doi:10.1016/j.seizure.2006.06.006
Nurten A, Özerman B, Özen İ, Kara İ (2009) The role of solid fluid intake in antimuscarinic-induced convulsions in fasted mice. Epilepsy Behav 15:142–145. doi:10.1016/j.yebeh.2009.03.025
Ohno Y, Ishihara S, Terada R, Serikawa T, Sasa M (2010) Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model. Epilepsy Res 89:360–364. doi:10.1016/j.eplepsyres.2010.01.011
Oliveira AA, Nogueira CRA, Nascimento VS, Aguiar LMV, Freitas RM, Sousa FCF, Viana GSB, Fonteles MMF (2005) Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement. Neurosci Lett 383:184–188. doi:10.1016/j.neulet.2005.05.048
Poulsen CF, Simeone TA, Maar TE, Smith-Swintosky V, White HS, Schousboe A (2004) Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons. Neurochem Res 29:275–282. doi:10.1023/B:NERE.0000010456.92887.3b
Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136:659–672. doi:10.1038/sj.bjp.0704766
Roth MT, Fleegal MA, Lydic R, Baghdoyan HA (1996) Pontine acetylcholine release is regulated by muscarinic autoreceptors. Neuroreport 7:3069–3072. doi:10.1097/00001756-199611250-00055
Senanayake N (1994) Reflex epilepsies: experience in Sri Lanka. Ceylon Med J 39:67–74
Simeone TA, Wilcox KS, White HS (2011) c-AMP-dependent protein kinase A activity modulates topiramate potentiation of GABA(A) receptors. Epilepsy Res 96:176–179. doi:10.1016/j.eplepsyres.2011.05.009
Striano S, Coppola A, del Gaudio L, Striano P (2012) Reflex seizures and reflex epilepsies: old models for understanding mechanisms of epileptogenesis. Epilepsy Res 100:1–11. doi:10.1016/j.eplepsyres.2012.01.013
Tan U, Şenyuva F, Marangoz C (1978) Electrocorticographic effects of topically applied scopolamine. Epilepsia 19:223–232. doi:10.1111/j.1528-1157.1978.tb04484.x
Turski WA, Cavalheiro EA, Bortolotto ZA, Mello LM, Schwarz M, Turski L (1984) Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res 321:237–253. doi:10.1016/0006-8993(84)-90177.X
Vannucchi MG, Pepeu G (1995) Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neurosci Lett 190:53–56. doi:10.1016/0304-3940(95)-11498-L
Wasterlain CG, Jonec V (1983) Chemical kindling by muscarinic amygdaloid stimulation in the rat. Brain Res 271:311–323. doi:10.1016/0006-8993(83)-90293-7
Watanabe H, Shimizu H (1989) Effect of anticholinergic drugs on striatal acetylcholine release and motor activity in freely moving rats studied by brain microdialysis. Jpn J Pharmacol 51:75–82. doi:10.1254/jjp.51.75
Zarrindast MR, Nouraei N, Khallilzadeh A, Askari E (2006) Influence of acute and sub-chronic nicotine pretreatment on morphine state-dependent learning. Behav Brain Res 173:268–273. doi:10.1016/j.bbr.2006.06.032
Zona C, Ciotti MT, Avoli M (1997) Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett 231:123–126. doi:10.1016/S0303-3940(97)00543-0
Acknowledgments
The authors would like to thank David Chapman (Language Editor, Istanbul Faculty of Medicine) for editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance with ethical standards
All studies were approved by the Istanbul University Local Ethics Committee on Animal Experiments (35/17.05.2007) and were in accordance with EU Directive 2010/63/EU on the protection of animals used for scientific purposes.
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(MP4 3285 kb)
Rights and permissions
About this article
Cite this article
Büget, B., Türkmen, A.Z., Allahverdiyev, O. et al. Antimuscarinic-induced convulsions in fasted animals after food intake: evaluation of the effects of levetiracetam, topiramate and different doses of atropine. Naunyn-Schmiedeberg's Arch Pharmacol 389, 57–62 (2016). https://doi.org/10.1007/s00210-015-1175-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-015-1175-5